tirzepatide for migraines Does (a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist) help alleviate migraine headaches? Migraines and Mounjaro: Separating Side

Wei and colleagues (Wei et al., 2022) recently discovered that GLP-1 receptor activation inhibits this signaling pathway by modulating ROCK activity, leading to a reduction in the phosphorylation of MLC, which stabilizes the endothelial cell cytoskeleton and tight junctions by upregulating the expression of tight junction proteins such as Occludin and ZO-1

This combination might create a situation where the stomach empties slowly while acid production increases, potentially intensifying nausea and acid reflux in some individuals

doi: 10.1007/s12020-021-02879-8 59 PatrizioAFerrariSMAntonelliAFallahiP

So, it's possible the effects aren't identical to those of traditional weight loss